Ajasja Ljubetič

Ajasja Ljubetič

Auto-generated profile, based on publicly available information

Ajasja Ljubetič

Department of Synthetic Biology and Immunology, Ljubljana, National Institute of Chemistry, 1000 Ljubljana, Slovenia

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2022 in Science Translational Medicine
Verified
Journal Article
Open access
AHAndrew C. Hunt
Andrew C. Hunt
JCJames Brett Case
James Brett Case
YPYoung-Jun Park
Young-Jun Park
LCLongxing Cao
Longxing Cao
KWKejia Wu
Kejia Wu
DBDavid Baker
David Baker
New variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue to arise and prolong the coronavirus disease 2019 (COVID-19) pandemic. Here, we used a cell-free expression workflow to rapidly screen and optimize constructs containing multiple computationally designed miniprotein inhibitors of SARS-CoV-2. We found the broadest efficacy was achieved with a homotrimeric version of the 75-residue angiotensin-converting enzyme 2 (ACE2) mimic AHB2 (TRI2-2) designed to geometrically match the trimeric spike architecture. Consistent with the design model, in the cryo-electron microscopy structure TRI2-2 forms a tripod at the apex of the spike protein that engaged all three receptor binding domains simultaneously. TRI2-2 neutralized Omicron (B.1.1.529), Delta (B.1.617.2), and all other variants tested with greater potency than the monoclonal antibodies used clinically for the treatment of COVID-19. TRI2-2 also conferred prophylactic and therapeutic protection against SARS-CoV-2 challenge when administered intranasally in mice. Designed miniprotein receptor mimics geometrically arrayed to match pathogen receptor binding sites could be a widely applicable antiviral therapeutic strategy with advantages over antibodies in greater resistance to viral escape and antigenic drift, and advantages over native receptor traps in lower chances of autoimmune responses.

6 June 2017 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
IDIgor Drobnak
Igor Drobnak
HGHelena Gradišar
Helena Gradišar
ALAjasja Ljubetič
Ajasja Ljubetič
EMEstera Merljak
Estera Merljak
RJRoman Jerala
Roman Jerala

1 October 2017 in Current Opinion in Chemical Biology
Verified
Journal Article
Closed access
ALAjasja Ljubetič
Ajasja Ljubetič
HGHelena Gradišar
Helena Gradišar
RJRoman Jerala
Roman Jerala

25 January 2022 in Nature Machine Intelligence
Verified
Journal Article
Closed access
PDF file
JLJohannes Linder
Johannes Linder
AFAlyssa La Fleur
Alyssa La Fleur
ZCZibo Chen
Zibo Chen
ALAjasja Ljubetič
Ajasja Ljubetič
DBDavid Baker
David Baker
GSGeorg Seelig
Georg Seelig

8 July 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
VFVida Forstnerič
Vida Forstnerič
KIKarolina Ivičak-Kocjan
Karolina Ivičak-Kocjan
ALAjasja Ljubetič
Ajasja Ljubetič
RJRoman Jerala
Roman Jerala
MBMojca Benčina
Mojca Benčina
Toll-like receptor 5 (TLR5) is a receptor of the innate immune system that recognizes flagellin from certain bacterial species and triggers an inflammatory response. The Salmonella dublin flagellin in complex with zebrafish TLR5 has been crystallized previously. In the present study, we extrapolate the structure of this complex using structure-guided mutagenesis to determine the recognition modes of human and mouse TLR5 receptors and demonstrate species-specific differences in flagellin recognition. In general, the recognition mode of the mouse receptor can be said to be more robust in comparison to that of the human receptor. All-atom molecular dynamics simulation showed differences between the two receptors within the primary binding region. Using a functional motility assay, we show that although the highly conserved area of the flagellin analyzed in this study encompasses key structural requirements for flagella formation, a direct correlation between immune recognition and structure on the level of amino acid residues is not observed.

29 November 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
JLJulia Koehler Leman
Julia Koehler Leman
SLSergey Lyskov
Sergey Lyskov
SLSteven M. Lewis
Steven M. Lewis
JAJared Adolf-Bryfogle
Jared Adolf-Bryfogle
RARebecca F. Alford
Rebecca F. Alford
RBRichard Bonneau
Richard Bonneau
Each year vast international resources are wasted on irreproducible research. The scientific community has been slow to adopt standard software engineering practices, despite the increases in high-dimensional data, complexities of workflows, and computational environments. Here we show how scientific software applications can be created in a reproducible manner when simple design goals for reproducibility are met. We describe the implementation of a test server framework and 40 scientific benchmarks, covering numerous applications in Rosetta bio-macromolecular modeling. High performance computing cluster integration allows these benchmarks to run continuously and automatically. Detailed protocol captures are useful for developers and users of Rosetta and other macromolecular modeling tools. The framework and design concepts presented here are valuable for developers and users of any type of scientific software and for the scientific community to create reproducible methods. Specific examples highlight the utility of this framework, and the comprehensive documentation illustrates the ease of adding new tests in a matter of hours.